288 related articles for article (PubMed ID: 17198943)
21. [Late complications following renal transplantation].
Bemelman FJ; ten Berge RJ
Ned Tijdschr Geneeskd; 2008 Jun; 152(23):1317-21. PubMed ID: 18661857
[TBL] [Abstract][Full Text] [Related]
22. Generalized lymphedema in a sirolimus-treated renal transplant patient.
De Bartolomeis C; Collini A; Rumberger B; Barni R; Ruggieri G; Bernini M; Carmellini M
Clin Transplant; 2008; 22(2):254-7. PubMed ID: 18339149
[TBL] [Abstract][Full Text] [Related]
23. Issues of obesity in kidney transplantation.
Kent PS
J Ren Nutr; 2007 Mar; 17(2):107-13. PubMed ID: 17321949
[TBL] [Abstract][Full Text] [Related]
24. Early clinical assessment of glucose metabolism in renal allograft recipients: diagnosis and prediction of post-transplant diabetes mellitus (PTDM).
Kuypers DR; Claes K; Bammens B; Evenepoel P; Vanrenterghem Y
Nephrol Dial Transplant; 2008 Jun; 23(6):2033-42. PubMed ID: 18174264
[TBL] [Abstract][Full Text] [Related]
25. Immunosuppression and metabolic syndrome in renal transplant recipients.
Lo A
Metab Syndr Relat Disord; 2004; 2(4):263-73. PubMed ID: 18370695
[TBL] [Abstract][Full Text] [Related]
26. Posttransplant diabetes mellitus in cyclosporine-treated renal allograft patients: a case-control study.
Copstein LA; Zelmanovitz T; Gonçalves LF; Manfro RC
Transplant Proc; 2004 May; 36(4):882-3. PubMed ID: 15194302
[TBL] [Abstract][Full Text] [Related]
27. [Neurological complications in renal transplant recipients].
Basić-Jukić N; Basić-Kes V; Kes P; Furić-Cunko V; Bacić-Baronica K
Acta Med Croatica; 2008; 62 Suppl 1():76-81. PubMed ID: 18578336
[TBL] [Abstract][Full Text] [Related]
28. [Posttransplant diabetes. Metabolic consequences of posttransplant immunosuppressive treatment].
Christiansen E
Ugeskr Laeger; 2007 Jun; 169(24):2309-11. PubMed ID: 17594845
[TBL] [Abstract][Full Text] [Related]
29. Long-term management of the liver transplant patient: diabetes, hyperlipidemia, and obesity.
Reuben A
Liver Transpl; 2001 Nov; 7(11 Suppl 1):S13-21. PubMed ID: 11689772
[TBL] [Abstract][Full Text] [Related]
30. Post-liver transplant obesity and diabetes.
T D Correia MI; Rego LO; Lima AS
Curr Opin Clin Nutr Metab Care; 2003 Jul; 6(4):457-60. PubMed ID: 12806221
[TBL] [Abstract][Full Text] [Related]
31. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
[TBL] [Abstract][Full Text] [Related]
32. Management strategies for posttransplant hypertension.
Midtvedt K; Neumayer HH
Transplantation; 2000 Dec; 70(11 Suppl):SS64-9. PubMed ID: 11152234
[TBL] [Abstract][Full Text] [Related]
33. Immunosuppressive medications, clinical and metabolic parameters in new-onset diabetes mellitus after kidney transplantation.
Roland M; Gatault P; Doute C; Büchler M; Al-Najjar A; Barbet C; Chatelet V; Marlière JF; Nivet H; Lebranchu Y; Halimi JM
Transpl Int; 2008 Jun; 21(6):523-30. PubMed ID: 18266773
[TBL] [Abstract][Full Text] [Related]
34. Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology.
Valantine H
J Heart Lung Transplant; 2007 Jun; 26(6):557-64. PubMed ID: 17543777
[TBL] [Abstract][Full Text] [Related]
35. Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens.
DuBay D; Smith RJ; Qiu KG; Levy GA; Lilly L; Therapondos G
Liver Transpl; 2008 May; 14(5):651-9. PubMed ID: 18433069
[TBL] [Abstract][Full Text] [Related]
36. Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients.
Burroughs TE; Swindle J; Takemoto S; Lentine KL; Machnicki G; Irish WD; Brennan DC; Schnitzler MA
Transplantation; 2007 Apr; 83(8):1027-34. PubMed ID: 17452891
[TBL] [Abstract][Full Text] [Related]
37. Surgical complications and renal function after kidney alone or simultaneous pancreas-kidney transplantation: a matched comparative study.
Gutiérrez P; Marrero D; Hernández D; Vivancos S; Pérez-Tamajón L; Rodríguez de Vera JM; Alarcó A; González-Posada JM
Nephrol Dial Transplant; 2007 May; 22(5):1451-5. PubMed ID: 17327283
[TBL] [Abstract][Full Text] [Related]
38. [Medical care of renal transplant recipients after the first year post-transplantation].
de Seigneux S; Hadaya K
Rev Med Suisse; 2008 Mar; 4(147):596-8, 600-1. PubMed ID: 18402018
[TBL] [Abstract][Full Text] [Related]
39. Significance and management of proteinuria in kidney transplant recipients.
Amer H; Cosio FG
J Am Soc Nephrol; 2009 Dec; 20(12):2490-2. PubMed ID: 19820126
[TBL] [Abstract][Full Text] [Related]
40. Treatment of post-transplant diabetic patients.
White JR; Campbell RK
Clin Ther; 1993; 15(2):261-71; discussion 215. PubMed ID: 8519036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
